{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:03:22Z","timestamp":1790510602436,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00259-013-2462-3","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T12:06:09Z","timestamp":1370433969000},"page":"1523-1531","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacokinetic analysis of [18F]FAZA in non-small cell lung cancer patients"],"prefix":"10.1007","volume":"40","author":[{"given":"Eline E.","family":"Verwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris H. P.","family":"van Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idris","family":"Bahce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maqsood","family":"Yaqub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Raijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A.","family":"Lammertsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Boellaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"issue":"2","key":"2462_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26(2):225\u201339.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"2462_CR2","first-page":"253","volume":"46","author":"SM Eschmann","year":"2005","unstructured":"Eschmann SM, Paulsen F, Reimold M, Dittmann H, Welz S, Reischl G, et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. J Nucl Med 2005;46(2):253\u201360.","journal-title":"J Nucl Med"},{"issue":"13","key":"2462_CR3","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.2005.05.2878","volume":"24","author":"D Rischin","year":"2006","unstructured":"Rischin D, Hicks RJ, Fisher R, Binns D, Corry J, Porceddu S, et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 2006;24(13):2098\u2013104.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2462_CR4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.2967\/jnumed.106.038570","volume":"48","author":"R Beck","year":"2007","unstructured":"Beck R, R\u00f6per B, Carlsen JM, Huisman MC, Lebschi JA, Andratschke N, et al. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine. J Nucl Med 2007;48(6):973\u201380.","journal-title":"J Nucl Med"},{"issue":"2","key":"2462_CR5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ijrobp.2007.05.079","volume":"69","author":"AL Grosu","year":"2007","unstructured":"Grosu AL, Souvatzoglou M, R\u00f6per B, Dobritz M, Wiedenmann N, Jacob V, et al. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007;69(2):541\u201351.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2462_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.radonc.2009.08.026","volume":"92","author":"M Busk","year":"2009","unstructured":"Busk M, Horsman MR, Jakobsen S, Hansen KV, Bussink J, van der Kogel A, et al. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 2009;92(3):429\u201336.","journal-title":"Radiother Oncol"},{"issue":"5","key":"2462_CR7","first-page":"500","volume":"54","author":"M Arabi","year":"2010","unstructured":"Arabi M, Piert M. Hypoxia PET\/CT imaging: implications for radiation oncology. Q J Nucl Med Mol Imaging 2010;54(5):500\u20139.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"Suppl 2","key":"2462_CR8","doi-asserted-by":"crossref","first-page":"129S","DOI":"10.2967\/jnumed.107.045914","volume":"49","author":"KA Krohn","year":"2008","unstructured":"Krohn KA, Link JM, Mason RP. Molecular imaging of hypoxia. J Nucl Med 2008;49 Suppl 2:129S\u201348.","journal-title":"J Nucl Med"},{"issue":"6","key":"2462_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1053\/j.semnuclmed.2007.07.001","volume":"37","author":"ST Lee","year":"2007","unstructured":"Lee ST, Scott AM. Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole. Semin Nucl Med 2007;37(6):451\u201361.","journal-title":"Semin Nucl Med"},{"issue":"3","key":"2462_CR10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01081524","volume":"22","author":"A Nunn","year":"1995","unstructured":"Nunn A, Linder K, Strauss HW. Nitroimidazoles and imaging hypoxia. Eur J Nucl Med 1995;22(3):265\u201380.","journal-title":"Eur J Nucl Med"},{"issue":"3","key":"2462_CR11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0969-8051(02)00442-0","volume":"30","author":"D Sorger","year":"2003","unstructured":"Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, et al. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Nucl Med Biol 2003;30(3):317\u201326.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"2462_CR12","first-page":"203","volume":"10","author":"G Reischl","year":"2007","unstructured":"Reischl G, Dorow DS, Cullinane C, Katsifis A, Roselt P, Binns D, et al. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA\u2013first small animal PET results. J Pharm Pharm Sci 2007;10(2):203\u201311.","journal-title":"J Pharm Pharm Sci"},{"issue":"10","key":"2462_CR13","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1007\/s00259-011-1876-z","volume":"38","author":"R Garcia-Parra","year":"2011","unstructured":"Garcia-Parra R, Wood D, Shah RB, Siddiqui J, Hussain H, Park H, et al. Investigation on tumor hypoxia in resectable primary prostate cancer as demonstrated by 18F-FAZA PET\/CT utilizing multimodality fusion techniques. Eur J Nucl Med Mol Imaging 2011;38(10):1816\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"2462_CR14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00259-007-0424-3","volume":"34","author":"M Souvatzoglou","year":"2007","unstructured":"Souvatzoglou M, Grosu AL, R\u00f6per B, Krause BJ, Reischl G, Picchio M, et al. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study. Eur J Nucl Med Mol Imaging 2007;34(10):1566\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"2462_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/0284186X.2010.510145","volume":"49","author":"M Schuetz","year":"2010","unstructured":"Schuetz M, Schmid MP, P\u00f6tter R, Kommata S, Georg D, Lukic D, et al. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncol 2010;49(7):941\u20137.","journal-title":"Acta Oncol"},{"issue":"7","key":"2462_CR16","doi-asserted-by":"crossref","first-page":"922","DOI":"10.3109\/0284186X.2010.503970","volume":"49","author":"M Busk","year":"2010","unstructured":"Busk M, Munk OL, Jakobsen S, Wang T, Skals M, Steiniche T, et al. Assessing hypoxia in animal tumor models based on pharmacokinetic analysis of dynamic FAZA PET. Acta Oncol 2010;49(7):922\u201333.","journal-title":"Acta Oncol"},{"issue":"9","key":"2462_CR17","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2967\/jnumed.109.074336","volume":"51","author":"K Shi","year":"2010","unstructured":"Shi K, Souvatzoglou M, Astner ST, Vaupel P, N\u00fcsslin F, Wilkens JJ, et al. Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors. J Nucl Med 2010;51(9):1386\u201394.","journal-title":"J Nucl Med"},{"issue":"6","key":"2462_CR18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.apradiso.2004.12.004","volume":"62","author":"G Reischl","year":"2005","unstructured":"Reischl G, Ehrlichmann W, Bieg C, Solbach C, Kumar P, Wiebe LI, et al. Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation. Appl Radiat Isot 2005;62(6):897\u2013901.","journal-title":"Appl Radiat Isot"},{"issue":"Suppl S1","key":"2462_CR19","doi-asserted-by":"crossref","first-page":"S1052","DOI":"10.1002\/jlcr.25804401375","volume":"44","author":"AD Windhorst","year":"2001","unstructured":"Windhorst AD, Linden TT, de Nooij A, Keus JF, Buijs FL, Schollema PE, et al. A complete, multipurpose, low cost, fully automated and GMP compliant radiosynthesis system. J Labelled Comp Radiopharm 2001;44(Suppl S1):S1052\u20134.","journal-title":"J Labelled Comp Radiopharm"},{"issue":"Suppl 1","key":"2462_CR20","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med 2009;50 Suppl 1:11S\u201320.","journal-title":"J Nucl Med"},{"issue":"1","key":"2462_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00259-009-1297-4","volume":"37","author":"R Boellaard","year":"2010","unstructured":"Boellaard R, O\u2019Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET\/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging 2010;37(1):181\u2013200.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2462_CR22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s002590000405","volume":"28","author":"R Boellaard","year":"2001","unstructured":"Boellaard R, van Lingen A, van Balen SC, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med 2001;28(1):81\u20139.","journal-title":"Eur J Nucl Med"},{"issue":"6","key":"2462_CR23","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","volume":"21","author":"RN Gunn","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ. Positron emission tomography compartmental models. J Cereb Blood Flow Metab 2001;21(6):635\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"17","key":"2462_CR24","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1088\/0031-9155\/51\/17\/007","volume":"51","author":"M Yaqub","year":"2006","unstructured":"Yaqub M, Boellaard R, Kropholler MA, Lammertsma AA. Optimization algorithms and weighting factors for analysis of dynamic PET studies. Phys Med Biol 2006;51(17):4217\u201332.","journal-title":"Phys Med Biol"},{"issue":"1","key":"2462_CR25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00004647-199601000-00005","volume":"16","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Bench CJ, Hume SP, Osman S, Gunn K, Brooks DJ, et al. Comparison of methods for analysis of clinical [11C]raclopride studies. J Cereb Blood Flow Metab 1996;16(1):42\u201352.","journal-title":"J Cereb Blood Flow Metab"},{"key":"2462_CR26","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"AC-19","author":"H Akaike","year":"1974","unstructured":"Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control 1974;AC-19:716\u201323.","journal-title":"IEEE Trans Autom Control"},{"issue":"11","key":"2462_CR27","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1118\/1.2794176","volume":"34","author":"G Glatting","year":"2007","unstructured":"Glatting G, Kletting P, Reske SN, Hohl K, Ring C. Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. Med Phys 2007;34(11):4285\u201392.","journal-title":"Med Phys"},{"issue":"2","key":"2462_CR28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiology.213.2.r99nv37521","volume":"213","author":"Y Sugawara","year":"1999","unstructured":"Sugawara Y, Zasadny KR, Neuhoff AW, Wahl RL. Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology 1999;213(2):521\u20135.","journal-title":"Radiology"},{"issue":"1","key":"2462_CR29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2967\/jnumed.111.089292","volume":"53","author":"T Chan","year":"2012","unstructured":"Chan T. Computerized method for automatic evaluation of lean body mass from PET\/CT: comparison with predictive equations. J Nucl Med 2012;53(1):130\u20137.","journal-title":"J Nucl Med"},{"issue":"12","key":"2462_CR30","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1007\/s00259-008-0888-9","volume":"35","author":"M Busk","year":"2008","unstructured":"Busk M, Horsman MR, Jakobsen S, Bussink J, van der Kogel A, Overgaard J. Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging 2008;35(12):2294\u2013303.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2462_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1748-717X-6-165","volume":"6","author":"FC Maier","year":"2011","unstructured":"Maier FC, Kneilling M, Reischl G, Cay F, Bukala D, Schmid A, et al. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [18F]-fluoro-azomycinarabino-furanoside ([18F]FAZA). Radiat Oncol 2011;6(1):165.","journal-title":"Radiat Oncol"},{"issue":"1","key":"2462_CR32","first-page":"106","volume":"46","author":"M Piert","year":"2005","unstructured":"Piert M, Machulla HJ, Picchio M, Reischl G, Ziegler S, Kumar P, et al. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside. J Nucl Med 2005;46(1):106\u201313.","journal-title":"J Nucl Med"},{"issue":"12","key":"2462_CR33","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00259-011-1899-5","volume":"38","author":"P Cheebsumon","year":"2011","unstructured":"Cheebsumon P, Yaqub M, van Velden FH, Hoekstra OS, Lammertsma AA, Boellaard R. Impact of [(18)F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology. Eur J Nucl Med Mol Imaging 2011;38(12):2136\u201344.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"2462_CR34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0360-3016(92)91001-4","volume":"22","author":"WJ Koh","year":"1992","unstructured":"Koh WJ, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, et al. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys 1992;22(1):199\u2013212.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2462_CR35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0360-3016(96)00325-2","volume":"36","author":"JS Rasey","year":"1996","unstructured":"Rasey JS, Koh WJ, Evans ML, Peterson LM, Lewellen TK, Graham MM, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 1996;36(2):417\u201328.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2462-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-013-2462-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-013-2462-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:05:29Z","timestamp":1558713929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-013-2462-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["2462"],"URL":"https:\/\/doi.org\/10.1007\/s00259-013-2462-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,6]]}}}